- Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief
Kaufmann joins Ovid’s leadership team with responsibility for guiding clinical, medical, and regulatory strategy as the Company progresses a clinical pipeline of potential best- and first-in
- Ovid Therapeutics (OVID) Stock Price, News Analysis
Founded in 2014 and headquartered in New York, the company applies a precision medicine approach to target underlying mechanisms of disease in patients with genetic conditions affecting the central nervous system
- Ovid Therapeutics (OVID) Stock Price Overview
A detailed overview of Ovid Therapeutics Inc (OVID) stock, including real-time price, chart, key statistics, news, and more
- Ovid Therapeutics appoints Petra Kaufmann as chief medical . . .
Dr Kaufmann will oversee clinical, medical, and regulatory strategy as Ovid advances its pipeline of therapeutic candidates targeting neuronal imbalance-driven conditions
- Town of Ovid – Established 1794
TOWN OF OVID 2136 Brown Street PO Box 452 OVID, NY 14521
- Ovid Therapeutics Names Petra Kaufmann Chief Medical Officer
She joins Ovid from Vigil Neuroscience—recently acquired by Sanofi—where she served as Chief Medical Officer and oversaw medical, clinical, biomarker, patient advocacy, and regulatory
- Ovid Therapeutics - OVID - Stock Price Today - Zacks
Get the latest Ovid Therapeutics OVID detailed stock quotes, stock data, Real-Time ECN, charts, stats and more
|